Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
Authors:
Open Access
- 1 January 2017
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 9 (1) , 21-29
Abstract
Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatmentKeywords
This publication has 96 references indexed in Scilit:
- HIF2α Acts as an mTORC1 Activator through the Amino Acid Carrier SLC7A5Molecular Cell, 2012
- Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer ProgressionCancer Research, 2011
- L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma.2011
- High expression of L‐type amino‐acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non‐cancerous lesionsPathology International, 2011
- Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancerExperimental and Therapeutic Medicine, 2010
- Properties of L-Type Amino Acid Transporter 1 in Epidermal Ovarian CancerInternational Journal of Gynecological Cancer, 2010
- L‐type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non‐small cell lung cancerHistopathology, 2009
- The c‐myc Promoter: Still MysterY and Challenge2008
- LAT2, a New Basolateral 4F2hc/CD98-associated Amino Acid Transporter of Kidney and IntestineJournal of Biological Chemistry, 1999
- Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinomaUrology, 1997